ACHE and Alzheimer disease: Among the existing pharmacological anti-AD interventions, acetylcholinesterase inhibitors are known to restore cholinergic neurotransmission, whereas N-methyl-D-aspartate (NMDA) receptor antagonists suppress the neuronal excitability towards NMDA [3].